Lv1
80 积分 2025-07-28 加入
Additive renoprotective effects of oral calcitriol on patients with IgA nephropathy receiving RAS blockers
1个月前
已完结
Atrasentan in Patients with IgA Nephropathy
2个月前
已完结
Low-Dose Corticosteroid Combined With Mycophenolate Mofetil for IgA Nephropathy With Stage 3 or 4 CKD: A Retrospective Cohort Study
5个月前
已完结
Glomerular galactose-deficient IgA1 and apoptosis inhibitor of macrophage staining in secondary IgA nephropathy associated with alcoholic cirrhosis
6个月前
已完结
The beneficial effect of adding belimumab in severe and refractory IgA nephropathy: a case report
8个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
8个月前
已完结
CKD progression, kidney failure, and mortality among US patients with IgA nephropathy
10个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
10个月前
已完结
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression
10个月前
已完结
Favorable changes in the eGFR slope after dapagliflozin treatment and its association with the initial dip
10个月前
已完结
皖公网安备34019202002308
